To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
The official print number for this legislation is 117_HR_6710.
This legislation was initiated in the House of Representatives.
The process officially started on 2022-02-11.
Key points include:
The current status is Expired.
The full official text is available at: View full text
The primary sponsor is Rep. Herrell, Yvette [R-NM-2].
The latest detailed status is: Referred to the Subcommittee on Health.
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.